COVID 19 Vaccine
COVID Status Certification (COVID Passports)
Guidance from Scottish Government on 13 April 2021:
Please do not contact your GP Practice to ask for a Covid vaccination passport or status certificate – they will not be able to provide any standard document. International certification standards have not yet been agreed.
The Scottish Government is working to support the re-opening of international travel once it is safe to do so. We are working with the other UK Nations and with the World Health Organisation to agree on potential future COVID certification requirements for international travel.
As part of this, we are developing a technical solution that could allow people to access their Covid vaccination status directly.
Updated 16 April 2021
We are also aware that there has been a delay with the invitations for the age group 60 - 64 going out. Patients in this age group should phone 0800 030 8013 to check.
The practice cannot advise or influence who will be on the next tier level for Covid-19 vaccinations, including patients who are in the high-risk group category. Please do not call or send a letter asking if you will be on the next level as we do not have any up-to-date information. All practices will be guided by the Scottish Government Guidelines when they become available.
Morningside Medical Practice has achieved the Scottish Government criteria for vaccinating all our patients who have been eligible for the Covid-19 vaccine at this time.
Due to the high demand on GP appointments, and if you require more information on the COVID vaccine we kindly ask our patients to look at the COVID vaccine leaflet (link above), by visiting NHS inform website or by calling 0800 030 8013 (open 7 days a week, 0800-2000).
Please click here for NHSInform Website which has multilingual leaflets about the COVID 19 Vaccine.
What is the aim?
The aim of the NHS Scotland and the Scottish Government is to offer COVID vaccination for all adults (aged 16+). The vaccine is your best protection against coronavirus.
We are delighted to have started our COVID19 Vaccination Clinics.
We have been asked to provide vaccines for ambulant patients, and in order according to JCVI (Joint Committee for Vaccination and Immunisation) priority groups, starting with patients:
- aged 80 and over (or will be by 31 March 2021),
- moving on to those aged 75-79,
- and then those who are shielding and aged over 16.
You can find out more about priority groups by clicking here. All group priorities are decided by the JCVI and GPs can not influence these decisions.
All other groups including housebound patients will be offered appointments via Health Board run services by letter. Healthcare and social care staff should contact their line manager.
We would strongly recommend that all adults get the vaccine as soon as it is offered to you.
The Pfizer COVID vaccine needs ultra-low temperature storage at -70°C which is possible at mass vaccination clinics organised by NHS Scotland, but not possible in GP surgeries. However, the Oxford-AstraZeneca COVID vaccine can be stored in regular fridge temperatures which GP practices will have access to.
NHS Scotland has ordered delivery of the Oxford/AstraZeneca COVID vaccine to GP practices, which was approved by the MHRA (medicines regulatory body) on 30 December 2020. Current evidence shows that the Oxford/AstraZeneca is safe and effective.
Due to the fast-moving pace of the COVID vaccine programme, please be aware that last-minute changes may occur, and we attempt to contact all patient should this occur. When booking an appointment, we will ask for an up to date mobile number if possible so we can organise mass text messages if needed. We apologise for any inconvenience should any last-minute changes occur.
Individuals will need two doses delivered between 3 to 12 weeks apart. Current evidence shows that individuals have good protection against COVID after the first vaccine dose, but have long term protection after their second dose.
Government recommendations for enhanced hand hygiene, social distancing and face coverings will still be required throughout and after the vaccination programme.
AstraZeneca Covid-19; precautionary temporary suspension in some EU countries
There has been a lot in the media about the temporary suspension by 11 European countries of the use of AZ vaccination on a precautionary basis following reports of blood clots.
The MHRA has provided a statement and publishes weekly data on reported side effects MHRA guidance .
For patients who ask, the following FAQ will be on the Covid Vaccine hub on the intranet
Q: I am concerned about safety of Astra-Zeneca vaccine and blood clots.
A: Blood clots can occur naturally and are not uncommon. More than 11m doses of the Astra Zeneca vaccine have been given in the UK; the number of blood clots that have been reported after vaccination are not more than would have been normally expected in that time frame.
The UK medicines regulatory authority (MHRA) is carefully scrutinising the reports of blood clots in the UK as well as the international data. The view of the MHRA experts is that the available evidence does not suggest the vaccine is the cause. Some countries have taken a highly precautionary approach and have temporarily suspended the use of the vaccine whilst they investigate.
Any suspension of vaccine has to be balanced against the know risks of Covid which is a serious disease, can be fatal, and itself can cause blood clots.
Therefore the MHRA experts recommend that people should still go and get their COVID-19 vaccine when asked to do so.
For more information, please see the MHRA guidance on precautionary temporary suspension of Astra-Zeneca vaccine.
Suspected Side effects should be reported in the usual way at https://coronavirus-yellowcard.mhra.gov.uk/ and on datix
Patients who have concerns about symptoms after vaccine should access healthcare in the usual way